Find latest Breast videos · 400+ videos
2024 ASCO® Annual Meeting Insights Hub
J

ASCO® 2024 Insights: "I-SPY2.2 Trial - Rates of pCR After Neoadjuvant Datopotamab Deruxtecan for High-Risk Stage 2/3 BC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Jane Meisel
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Jane Meisel
221 views
June 13, 2024

Chapters

I-SPY 2.2 Trial Design Overview

00:00

Dato-DXd Treatment Results & Future Plans

04:01

Comments 0
Login to view comments. Click here to Login

Featured Video

05:15
Lilly Medical Affairs

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

Related Videos

25:08

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

4.3K views
15:57

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

Sara Tolaney

H. Rugo

618 views
14:52

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

842 views
09:55

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

1.5K views
26:06

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

643 views
36:18

Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

1.2K views
33:44

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clini…

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

930 views
14:16

Year in Review: Breast Cancer

Dana-Farber Cancer Institute

P. Tarantino

2.4K views
10:34

ASCO® 2024 Noteworthy Abstracts in Breast Cancer

Sara Tolaney

H. Rugo

932 views
21:31

ESMO Breast 2024 Summary: "Community Oncologists Highlights"

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney, H. Rugo

1.1K views
05:43

Neoadjuvant Chemo for HR+ BC: Year in Review

Total Health

C. Ma

983 views
06:10

ESMO Breast 2024 Summary: "Is There a Role for Combining ADCs With t…

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney

847 views
21:28

New

Immunotherapy for TNBC: Remaining Questions and New Directions

Margaret Gatti-Mays

149 views
12:55

Advances in Targeted and Endocrine Therapies for Metastatic HR+/HER2…

UChicago Medicine

N. Chen

521 views
10:09

ESMO Breast 2024 Insights: "Pooled Analysis of T-DXd Retreatment Aft…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

673 views
22:34

What's New in Breast Cancer?

Dana-Farber Cancer Institute

S. Tolaney

1.6K views
09:34

ASCO® 2024 Insights: "Impact of ctDNA Surveillance on Clinical Care …

2024 ASCO® Annual Meeting Insights Hub

M. Lipsyc-Sharf

308 views
05:35

ESMO Breast 2024 Insights: "IMpassion132 Trial - Is There a Role for…

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney

524 views
06:37

ESMO 2024 Insights: Pembro or Placebo + CT in High-Risk Early TNBC -…

2024 ESMO Annual Meeting Insights Hub

H. McArthur

157 views
13:47

HR+ Advanced/Metastatic BC Treatment Options: Refining Endocrine Sen…

Stanford Medicine

M. Dolezal

1.1K views
AUTOPLAY